The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development

Peroxisome proliferator-activated receptors (PPARs) are a well-known pharmacological target for the treatment of multiple diseases, including diabetes mellitus, dyslipidemia, cardiovascular diseases and even primary biliary cholangitis, gout, cancer, Alzheimer’s disease and ulcerative colitis. The t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Fan, Xu, Pengfei, Zhai, Yonggong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121873/
https://www.ncbi.nlm.nih.gov/pubmed/30060458
http://dx.doi.org/10.3390/ijms19082189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121873/
https://www.ncbi.nlm.nih.gov/pubmed/30060458
http://dx.doi.org/10.3390/ijms19082189

Ejemplares similares